Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands
Brady K. Atwood(University of Washington), Ken Mackie(Indiana University Bloomington)
Cited by 152
Related Papers
JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB<sub>1</sub>receptor agonist
|British Journal of Pharmacology|2010|260
CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
|Molecular Pharmacology|2014|257
Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the<scp>CNS</scp>
|British Journal of Pharmacology|2013|251
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
|Frontiers in Molecular Neuroscience|2022|144